NDC 61133-0899 - Dexium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61133-0899
- Package NDCs from labels
- 61133-0899-9
- Manufacturer
- Bimeda, Inc. | Bimeda-MTC Animal Health
- Effective date
- 2024-04-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexium - Bimeda, Inc. | Bimeda-MTC Animal Health | Bimeda, Inc. | Bimeda-MTC Animal Health | 2024-04-23 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61133-0899-9 | Dexium | 100 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 100 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61133-0899 | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC.] | 9 | 1 package rows | 20240424_d6113f31-01d7-4e98-9c2c-33bd2ea82f42.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Dexamethasone | ACTIVE INGREDIENT | 7S5I7G3JQL | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 | |
| Dexamethasone | ACTIVE MOIETY | 7S5I7G3JQL | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 401ec088-984a-49ab-b317-747c2b9b9e22 | 2025-03-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 3166db4f-66a5-496a-a194-3cc01b7347d3 | 2025-03-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 2f780550-ecbf-98fc-e063-6294a90a11c0 | 2025-03-03 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | b883860c-27ba-4bac-8ae3-4cf4d82d5071 | 2025-02-10 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | b7b39ad5-e158-b8fe-e053-2995a90a5279 | 2025-02-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Prasco Laboratories | bfce6b49-f7ff-4ec7-9580-b730f0a207d7 | 2025-02-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sandoz Inc | 89fef4d2-7078-47f1-96bf-aca50b135a97 | 2025-01-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Redpharm Drug, Inc. | 115e1bfb-1697-d567-e063-6394a90a78e5 | 2025-01-23 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | e90cb7f5-5e99-fbf3-e053-2995a90a70aa | 2025-01-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | fade983c-81fb-df94-e053-6394a90a7560 | 2025-01-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 044d7898-4ab6-a0b3-e063-6294a90acdba | 2025-01-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| DEXAMETHASONE | DEXAMETHASONE | Direct Rx | cc7140de-a205-f675-e053-2995a90ac22b | 2025-01-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Eyevance Pharmaceuticals, LLC | c2d7325e-4f58-5590-e053-2a95a90ace1b | 2025-01-16 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 955db121-79f4-47eb-8c10-01b2d8b411e4 | 2025-01-13 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Advanced Rx of Tennessee, LLC | 09315f0b-f15a-30d5-e063-6394a90ac8dd | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Advanced Rx Pharmacy of Tennessee, LLC | f1a05d5f-74f2-17a1-e053-2995a90ab0e7 | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Advanced Rx Pharmacy of Tennessee, LLC | f4c00d9c-3a17-06a0-e053-2a95a90a8413 | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Advanced Rx Pharmacy of Tennessee, LLC | fa16db27-3c8c-eb22-e053-6394a90add59 | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | a7e55c43-4345-4710-e053-2995a90aeee7 | 2024-12-30 | Warnings, Adverse reactions | 7S5I7G3JQL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.